Nanotechnology, the research shows, could reprogram the immune system and help overcome tumors’ defenses, addressing the limitations of current immunotherapies, particularly in treating solid tumors.
DaeYong Lee, assistant professor at the Fralin Biomedical Research Institute at VTC, aims to use biomaterials to improve cancer immunotherapy and reduce disparities in treatment outcomes.